TCEANC

Chr X

transcription elongation factor A N-terminal and central domain containing

Also known as: TCEANC1

Predicted to enable transcription elongation factor activity. Predicted to be involved in transcription elongation by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jun 2026]

ResearchGenerating clinical summary…
0
Active trials
0
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.07
LOEUF
DN
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.07LOEUF
pLI 0.052
Z-score 1.46
OE 0.41 (0.19–1.07)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.28Z-score
OE missense 0.93 (0.79–1.09)
108 obs / 116.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.41 (0.19–1.07)
0≤0.351.4
Missense OE?0.93 (0.79–1.09)
0≤0.61.4
Synonymous OE?0.90
0≤1.21.6
LoF obs/exp: 3 / 7.2Missense obs/exp: 108 / 116.5Syn Z: 0.50

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TCEANC · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →